Singapore
+918265041513
+918265041513

Imatib 400mg (Generic Gleevec/Glivec) Birmingham — CML Leukaemia Treatment UK

Chronic Myeloid Leukaemia (CML) is a blood cancer that affects the bone marrow and blood, and Birmingham's oncology departments at major NHS trusts manage significant numbers of CML patients requiring long-term tyrosine kinase inhibitor (TKI) therapy. Imatib 400mg — the Indian generic of Gleevec/Glivec — is a cornerstone treatment for CML that has transformed patient outcomes over the past two decades.

Imatib contains Imatinib Mesylate 400mg, a first-generation BCR-ABL tyrosine kinase inhibitor that specifically targets the abnormal protein produced by the Philadelphia chromosome — the genetic abnormality that drives CML. Since its introduction, Imatinib has converted CML from a life-threatening leukaemia into a manageable chronic condition, with many patients achieving complete molecular remission.

For Birmingham's CML patients on NHS treatment, Imatinib is typically provided free. However, patients who travel, live abroad part-time, or require supply outside NHS channels — including international students and expatriates — rely on affordable Indian generics like Imatib. The medicine is also widely used for Gastrointestinal Stromal Tumours (GIST) and other BCR-ABL positive conditions.

Unnati Pharmax supplies Imatib 400mg to oncology pharmacies, haematology clinics, and patients in Birmingham and across the UK. Visit medshopy.com or WhatsApp +91 82650 41513 for supply details.
 2026-06-13T11:40:36

Other Pages

View all pages